The Costs of Misdiagnosis
Quality, not access, will define the future of global health. We've developed a platform to improve health-care quality worldwide.
Quality, not access, will define the future of global health. We've developed a platform to improve health-care quality worldwide.
The next era of public education will be judged less by the elegance of its ideas than by whether it responds, with humility and pragmatism, to the people it exists to serve.
Green hydrogen partnerships in the Middle East and North Africa are sidelining the civil society organizations they claim to empower, repeating the sins of colonialism.
Lessons from Brazil on how science philanthropy can and should act in the face of political hostility.
The Making Missing Markets initiative is marshaling funds and support groups to help towns across the United States.
To decarbonize infrastructure, we need to look beyond technological fixes and learn to build coalitions.
To meet the moment, we need to build the middle ground between philanthropy and commercial investing.
CEOs who take political stances command more credibility with the public when their companies embrace corporate social responsibility.
How philanthropy can walk alongside national governments to scale development solutions that deliver over time
Scaling effective solutions often stalls in state government because funding systems are not designed to reward proof of impact. A new partnership model shows how states and funders can unlock smarter public spending together.